Recruiting Stroke Studies in Sacramento
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
The primary objective is to establish the efficacy of intra-arterial (IA) mechanical thrombectomy (MT) with extracranial proximal carotid artery acute stenting versus non-stenting approaches in patien...
Strategy for Improving Stroke Treatment Response
SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alp...
About Stroke Clinical Trials in Sacramento
A stroke occurs when blood flow to part of the brain is interrupted or reduced, depriving brain tissue of oxygen and nutrients. It is a leading cause of disability and death. Rapid treatment is critical, and prevention focuses on managing risk factors like hypertension and atrial fibrillation.
There are currently 2 stroke clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 704 participants. Research is being sponsored by Mercy Health Ohio, Translational Sciences, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Stroke Clinical Trials in Sacramento — FAQ
Are there stroke clinical trials in Sacramento?
Yes, there are 2 stroke clinical trials currently recruiting in Sacramento, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Sacramento?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.
Are clinical trials in Sacramento free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.
What stroke treatments are being tested?
The 2 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for stroke.
Data updated March 2, 2026 from ClinicalTrials.gov